Scott D.Lyne

Partner

New York + 1.212.326.8382

Connect:

Share

Scott Lyne's practice focuses on corporate transactions, licensing, and counseling involving intellectual property and technology. He is a member of Jones Day's IP Transactions area. His experience includes the negotiation and structuring of IP purchases and sales, technology development and licensing agreements, manufacturing, distribution and supply agreements, and the IP and technology aspects of other corporate transactions, such as mergers and acquisitions, joint ventures, strategic alliances, asset securitizations, private equity investments, capital markets offerings, and secured lending.

In addition, Scott counsels clients on strategic IP and technology matters, including the development of strategies for the protection and exploitation of technologies and the enforcement of intellectual property rights, and works with clients on day-to-day operational issues relating to technology, intellectual property, electronic commerce, and privacy. He has worked with a wide range of clients in various industries, including public companies, as well as growing technology-driven businesses and start-ups.

Scott also has experience with intellectual property litigation. He has represented domestic and foreign clients on matters involving diverse technologies, such as semiconductors, business methods, and physical and life sciences, and has experience with actions arising before the United States International Trade Commission and through the Abbreviated New Drug Application (ANDA) process.

Experience

  • Sanofi, Orano Med, and RadioMedix collaborate to develop radioligand therapiesJones Day represented and supported Sanofi's in-house team in connection with an exclusive licensing agreement with RadioMedix, Inc., and Orano Med, subsidiary of the Orano Group.
  • Astellas enters into strategic collaboration and license agreement with Kelonia Therapeutics to develop novel immuno-oncology therapeuticsJones Day represented Xyphos Biosciences, Inc. (a wholly-owned subsidiary of Astellas Pharma Inc.) in connection with a research collaboration and license agreement with Kelonia Therapeutics, Inc. ("Kelonia"), a biotech company pioneering new genetic medicines using its in vivo gene placement system (iGPS®).
  • British American Tobacco Group and its subsidiaries settle global patent dispute with Philip Morris over heated tobacco and vapour productsJones Day advised British American Tobacco Group and its subsidiaries (BAT) in connection with its global settlement with Philip Morris International Inc (PMI) to resolve all ongoing patent infringement litigation between the parties related to heated tobacco and vapour products.
  • Cellectis and AstraZeneca enter into research collaboration and agree on equity investment of up to $220 million by AstraZenecaJones Day advised Cellectis in connection with the joint research collaboration agreement entered into with AstraZeneca and initial equity investment by AstraZeneca into Cellectis of $80 million.
  • J.F. Lehman completes financing in connection with its $1.2 billion take-private acquisition of Heritage-Crystal Clean, Inc.Jones Day represented J.F. Lehman & Company, a leading private equity investment firm focused on the aerospace, defense, maritime, and environmental sectors, in connection with a syndicated senior secured credit facility financing its approximately $1.2 billion take-private acquisition of Heritage-Crystal Clean, Inc. (NASDAQ: HCCI), a leading provider of parts cleaning, used oil re-refining, hazardous and non-hazardous waste disposal, emergency and spill response, and industrial and field services to vehicle maintenance businesses, manufacturers and other industrial businesses, as well as utilities and governmental entities.
  • Direct lender provides $151 million senior secured credit facility to private equity-backed API integration platformJones Day advised a direct lender, as administrative agent, sole lead arranger, and bookrunner, in connection with a $151 million senior secured credit facility provided to a large private equity sponsored company that provides a SaaS platform for building, deploying, and managing integrations between software applications.
  • BAT invests in Charlotte’s WebJones Day advised BAT Group in its investment in Charlotte's Web Holdings, Inc., the market leader in hemp-derived cannabidiol (CBD) wellness products.
  • GE Aerospace sells revolutionary hydrogen and fuel agnostic generator technology to HyliionJones Day advised GE Aerospace, part of GE, a world leader in the sale of metal additive technologies and manufacturing, in the sale of a new hydrogen and fuel agnostic capable generator ("KARNO") to Hyliion Holdings Corp., a leader in electrified powertrain solutions for Class 8 semi-trucks.
  • Newell Brands sells the Connected Home & Security business to Resideo TechnologiesJones Day advised Newell Brands Inc. in the $593 million sale of the Connected Home & Security (CH&S) business to Resideo Technologies, Inc.
  • Coya Therapeutics announces its initial public offeringJones Day represented Coya Therapeutics Inc. as IP counsel in connection with its December 2022 initial public offering.
  • ABM acquires Able Services for $830 millionJones Day advised ABM Industries Incorporated in the acquisition of Able Services, a leading facilities services company headquartered in San Francisco, in a cash transaction valued at $830 million.
  • SK Innovation resolves global patent dispute with LG Chem / LG Energy Solution over lithium-ion battery technologyJones Day advised SK Innovation Co., Ltd. and SK Battery America, Inc. in connection with the settlement of their global patent dispute with LG Chem Ltd. involving lithium-ion battery technology used in electric vehicles.
  • Bally's acquires Bet.Works for $125 million and announces strategic partnership with Sinclair BroadcastJones Day advised Bally's Corporation in its $125 million acquisition of Bet.Works, a U.S. based sports betting platform provider to operators in New Jersey, Iowa, Indiana, and Colorado, and a long-term strategic partnership with Sinclair Broadcast Group, Inc., pursuant to which 21 FOX RSN brands will be rebranded using the Bally’s name and Bally’s will integrate content into the 190 television stations that Sinclair owns, operates, or provides services to across 88 markets and sports networks.
  • PureCycle Technologies combines with Roth CH Acquisition I Co.Jones Day advised PureCycle Technologies LLC ("PureCycle") in its business combination with Roth CH Acquisition I Co. ("Roth SPAC"), a publicly-traded special purpose acquisition corporation backed by Roth Capital Partners and Craig-Hallum Capital Group, and Roth CH Acquisition I Co. Parent Corp., a wholly owned subsidiary of Roth CH ("Holdings"), among others.
  • U.S. Bank National Association acquires Debt Servicing and Securities Custody Services client portfolio of MUFG Union BankJones Day represented U.S. Bancorp, a bank holding company and the parent company of commercial bank U.S. Bank National Association, in its acquisition of the Debt Servicing and Securities Custody Services client portfolio of MUFG Bank N.A., a subsidiary of holding company MUFG Americas Holdings Corporation and a member of the Mitsubishi UFJ Financial Group.
  • Bally's acquires SportCallerJones Day advised Bally's Corporation in its acquisition of SportCaller, one of the leading B2B free-to-play (F2P) game providers for sports betting and media companies across North America, the UK, Europe, Asia, Australia, Latin America, and Africa.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • Marfrig and ADM launch joint venture PlantPlus FoodsJones Day represented Brazilian Marfrig Global Foods SA, one of the world's leading beef producers and the world's largest beef patty producer, in connection with the creation of PlantPlus Foods, a joint venture with U.S.-based Archer-Daniels-Midland Company, a leading global nutrition company, for the sale of plant-based food products across the South American and North American markets.
  • Twin River Worldwide Holdings acquires iconic Bally's brand from Caesars EntertainmentJones Day advised Twin River Worldwide Holdings, Inc. in the acquisition of the iconic Bally's brand previously owned by Caesars Entertainment, Inc.
  • TD Securities arranges $190 million acquisition financing for Whole Earth Brands, Inc.Jones Day advised TD Securities (USA) LLC, as arranger, in connection with a $190 million senior secured credit facility comprised of a $140 million term loan and a $50 million revolving credit facility to Whole Earth Brands, Inc, a special purpose acquisition company (SPAC).
    • View All

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.